Business Wire
23 Oct 2026, 20:33 UTC · 1h ago
Impact · against what's priced in
Quest Diagnostics faces potential financial and regulatory headwinds following a data breach in its Quanum Lab Services Manager platform. The news introduces new risks regarding remediation costs and legal liabilities that are not yet reflected in the stock price.
No priced-in read yet
What the story claims
2 claims · scored −1 bearish … +1 bullish · 2 new · 0 priced in
Quest Diagnostics identified unauthorized activity in its Quanum Lab Services Manager platform on October 21, 2026.
New8-K filing dated Oct 21, article dated Oct 23
So whatPotential regulatory fines and remediation costs will likely hit the P&L in Q4 2026 or FY2027.
More negative than 86% of claims this week
AWKO Law LLP is investigating the data breach regarding unauthorized access to Quest Diagnostics patient records.
Continue reading
5 related stories
The identification of unauthorized activity on October 21, 2026, and the subsequent legal investigation by AWKO Law LLP introduce unexpected costs for remediation and potential regulatory penalties.
Read from the article alone
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
Newbusiness wire announcement dated Oct 23
More negative than 69% of claims this week
Which stocks this story touches
More negative than 82% of ticker scores this week
The company is investigating a data breach involving unauthorized access to sensitive patient information.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
1h ago
—
DGX hasn't traded since this ran. Last close $241.89 (Oct 23); the reaction starts at the next open.
DGX chart →
